Form 4: Eli Lilly Executive Gifts Shares Under 10b5-1 Plan
Insider Transaction Report
Eli Lilly & Co. EVP Daniel Skovronsky reported gifting 179 shares of common stock on November 10, 2025, under a Rule 10b5-1 plan.
Summary
- Daniel Skovronsky, Executive Vice President, Corporate Strategy & Policy, and President, Lilly Research Laboratories (LRL) at Eli Lilly & Co. (LLY), reported a change in beneficial ownership.
- On November 10, 2025, Skovronsky disposed of 179 shares of common stock via a gift (transaction code 'G') at a price of $0.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged disposition.
- Following this transaction, Skovronsky directly beneficially owns 137,481.112 shares of common stock.
- Indirect beneficial ownership includes 72,359 shares held by a Trust, 547 shares held by a spouse, and 2,710 shares held by a spouse's SLAT.
- The filing corrects a 200-share discrepancy in holdings reported in a Form 4 filed on August 12, 2025, specifically related to shares held by the spouse and spouse's SLAT.
Sentiment
Score: 5
Explanation: This is a routine Form 4 filing reporting a gift of shares by an executive, which is a neutral event in terms of company performance or outlook. The transaction was pre-planned under Rule 10b5-1.
Positives
- The transaction was executed under a Rule 10b5-1 plan, suggesting a pre-planned disposition rather than a reaction to recent company performance or news.
Negatives
- A reduction in direct beneficial ownership by 179 shares, although this was a gift and not a sale for cash.
Future Outlook
No future outlook or guidance is provided in this insider transaction report.
Industry Context
This filing is a routine insider transaction report, reflecting an individual executive's personal portfolio management rather than broader industry trends or company-specific strategic developments.
Related Party Transactions
- The gift of shares to a trust and spouse constitutes a related party transaction, which is standard for insider reporting on Form 4.
Stakeholder Impact
- Shareholders may note a minor reduction in the direct beneficial ownership of an executive, but the transaction is a gift and represents a very small fraction of the executive's total holdings and the company's outstanding shares, thus having minimal impact.
Key Dates
| Date | Description |
|---|---|
| 2025-08-12 | Date of previous Form 4 filing that contained a 200-share discrepancy in reported holdings. |
| 2025-11-10 | Date of the reported transaction where 179 shares of common stock were gifted. |
Recommendation
holdThis Form 4 reports a routine, pre-planned gift of a small number of shares by an executive. Such transactions are generally not indicative of fundamental changes in the company's prospects or the executive's confidence, and therefore do not typically warrant a change in investment recommendation.
Keywords
Eli Lilly, LLY, Daniel Skovronsky, Form 4, Insider Transaction, Stock Ownership, Gift, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.